PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Company ReportsJiangsu Hengrui Medicine
Jiangsu Hengrui Medicine
Jiangsu Hengrui Pharmaceuticals Company Ltd. (Chinese: 江苏恒瑞医药股份有限公司), also known as Jiangsu Hengrui (Chinese: 恒瑞医药), is a Chinese pharmaceutical company that manufactures and distributes various types of drug packaging materials, cancer-treating antineoplastics, cardiovascular medication, painkillers, antibiotics, and related products. It is the largest listed pharmaceutical company in China.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
CarmustineCarmustine2021-03-12
CaspofunginCaspofungin2018-06-282032
Cisatracurium besylateCisatracurium besylate2017-01-27
CyclophosphamideCyclophosphamide2014-10-312035-2036
DaptomycinDaptomycin2019-08-222028-2041
DexmedetomidineDexmedetomidine2017-09-192032-2039
DocetaxelDocetaxel2017-02-152031-2036
FondaparinuxFondaparinux2018-05-15
GadobutrolGadobutrol2022-11-17
Gadoterate meglumineGadoterate meglumine2022-04-11
IodixanolIodixanol2022-05-19
IrinotecanIrinotecan2011-12-162025-2036
1
2
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Docetaxel
Irinotecan hydrochloride trihydrate
1
2
3
4
5
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use